The Alliance for Multispecialty Research (AMR) is a unique network of integrated, geographically diverse, and highly experienced Clinical Research Centers of Excellence. Chartered as a formal organization in 1994, AMR Centers of Excellence provide clinical trial services across a broad base of therapeutic areas to the pharmaceutical, biotechnology, nutrition and medical device industries.
To learn more about AMR’s fully integrated network, click here: amrllc.com.

CKRA News

Osteoarthritis of the Hip or Knee

  • December 11, 2015

The purpose of this research study is to evaluate the long-term safety and effectiveness of an investigational medication in subjects with osteoarthritis of the hip or knee.
Duration:  Approximately 21 months
Number of visits to CKRA: At least 15
Reimbursement for Travel Expenses:  Up to $560 for completion
Note:  Qualified participants must be at least 18 years old who have been diagnosed with osteoarthritis of the hip or knee, and be taking naproxen, celecoxib, or diclofenac for hip or knee pain at least 5 days per week.  Other criteria also apply.

Osteoarthritis of the Knee Study - Interest Form

If you are interested in participating in this study, please fill out the form below. This will help us determine if you meet some of the initial criteria necessary to participate. We will contact you within 48 hours to go over the study details and answer any questions that you, or we, may have. Per CKRA's privacy policy, all of your personal information that we have obtained will be kept in our secure database, which can only be accessed by authorized CKRA personnel, unless given your permission or except as required by law.